A.T. Kearney Releases Report Designed to Help Achieve Stakeholder Confidence in Mobile Health
13 November 2012 (London)—Global management consultancy A.T. Kearney (in association with the GSMA) today released its latest report on the mobile health industry. The review identifies a need to shift emphasis away from the traditional focus of proving the merits of the technology in isolation and instead focus on demonstrating the health economic benefits of mobile health within a healthcare system. Overcoming this trend will help mobile health reach the scale of adoption that many stakeholders have desired.
Doctor Imran Hamid, associate at A.T. Kearney, commented:
"We are publishing this report to help address the failings in the aims and methodology used in current research. Our report is designed to help sponsors of research to ensure that future studies are relevant to key stakeholders, use appropriate study designs and employ robust methodologies."
While the report recognizes that the uptake of mobile health has been slow, the authors outlined a number of key hurdles that need to be addressed in future research.
- Safety is considered to be the first hurdle for the successful development of any new medical intervention, technology or service. Providers should expect that regulatory approval will always be an important part of the pathway to wider adoption and that regulatory guidance will continue to evolve in the coming years.
- After proving that a mobile health solution is safe to use, the clinical benefit of the solution should be determined by understanding how well it achieves its intended purpose. Proof that mobile health solutions have a tangible clinical benefit must be based on robust, non-biased, statistically significant evidence.
- The economic impact of the proposed mobile health solution needs to be carefully evaluated, as this is a critical factor for the adoption of any new technology in virtually all healthcare systems. Only when a mobile health solution has been deemed to achieve a tangible benefit at a reasonable cost is it likely to be adopted by providers or reimbursed by healthcare contributors.
Jonathan Anscombe, partner and head of the Health Practice, concluded: "Despite the growth in the quantity of evidence published, the focus of the research has not been concentrating on the issues that address the main hurdles to adoption such as clinical outcome, cost, and the impact on the wider healthcare system. To accelerate growth and adoption of mobile health we strongly recommend that future research should focus on addressing these key issues."
About A.T. Kearney
A.T. Kearney is a global team of forward-thinking, collaborative partners that delivers immediate, meaningful results and long-term transformative advantage to clients. Since 1926, we have been trusted advisors on CEO-agenda issues to the world's leading organizations across all major industries and sectors. A.T. Kearney's offices are located in major business centers in 39 countries.